Winner
Sanofi and Lancashire and South Cumbria Cancer Alliance – Improving suspected Skin cancer care
Partner(s): Lancashire and South Cumbria Cancer Alliance, (NHS Lancashire and South Cumbria Integrated Care Board)
Executive Summary
In 2022 there were significant concerns in Lancashire and South Cumbria (L&SCCA)Urgent Suspected Skin Cancer Pathway. Delivery of the 28 Day Faster Diagnosis (FDS) standard dropped to 67% in October/November 22 (NHS standard is 75%).There were 23,000 referrals on to the Urgent Suspected Skin Cancer Pathway from Primary Care in 2022/2023 and have been rising on average around 10-15% yearon year. In response to increase in skin cancer referrals and worsening 28 FDS delivery, the L&SCCA in collaboration with Sanofi, undertook a collaborative working project to reassess the suspected skin cancer pathway. The imperative was to work with key stakeholders to streamline processes, enhance efficiency and ensure patients are directed to the right place, the first time. In addition, through conduction of the pathway analysis, key themes emerged, including the critical importance of comprehensive education and support mechanisms for healthcare professionals to support their diagnostic capabilities. Tailored educational initiatives focused on dermatology for primary care professionals. Therefore, the Alliance, supported by a Sanofi grant, developed a suite of educational videos focusing on skin cancer recognition, dermatitis, eczema, and actinic keratosis.These videos aim to empower healthcare professionals with more accurate diagnosis first time and improve patient outcomes.
Finalist
Promatica and Dexcom Partnership with SSP GP Federation
Executive Summary
Promatica developed first-of-type software called PRISM that integrates with EMIS and SystmOne to identify and then triage patients who met NICE criteria for CGM prescribing. Starting small with two practices in the SSP federation, it has now been adopted by all 35 practices (which has resulted in further, nationwide adoption). By partnering with Dexcom, the software and service was provided at no cost to the NHS, and has resulted in reduction in appointments and referrals, as well as decreases in medication and consumables spend. On service completion, PRISM then invited patients to share their CGM data with their medical record. This not only addresses a gap in diabetes data in the primary care dataset, but facilitates both proactive and opportunistic review of diabetes control, saving time for clinicians and mitigating the clinical risk associated with working between multiple applications. Thanks to QOF, the diabetes key care processes and the National Diabetes Audit, there is rich data available for diabetes management. Glaring omissions, however, are interstitial glucose, time in range and GMI. This partnership not only expedited the process of getting the right patients onto the right diabetes technology, but it is informing strategic care planning by enriching Primary Care data.
